Macrophage-inhibitory cytokine-1 (MIC-1) in differential diagnosis of dyspnea - a pilot study
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F09%3A00002101" target="_blank" >RIV/62157124:16370/09:00002101 - isvavai.cz</a>
Výsledek na webu
—
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Macrophage-inhibitory cytokine-1 (MIC-1) in differential diagnosis of dyspnea - a pilot study
Popis výsledku v původním jazyce
Background: Macrophage inhibitory cytokine-1 (MIC-1) has recently been associated with markers of heart function. Aim: This study sought to verify the relationship between markers of heart function (New York Heart Association classification (NYHA)): leftventricle ejection fraction (LVEF), N terminal prohormone of natriuretic peptide B type (NT-proBNP) and MIC-1. Furthermore, the assessment of the usefulness of these markers for differential diagnosis of the myocardial form of dyspnea was explored. Methods: 124 patients (65 women and 59 men) were examined for dyspnea without signs of acute coronary syndrome. All patients underwent echocardiography (calculation of left ventricle ejection fraction-LVEF), and serum NT-proBNP and MIC-1 were determined. 21healthy individuals were defined as the control group. Results and discussion: Patients were divided into two groups: A-individuals with non-cardiogenic form of dyspnea, n = 77 and B-individuals with cardiogenic ethiology of dyspnea, n =
Název v anglickém jazyce
Macrophage-inhibitory cytokine-1 (MIC-1) in differential diagnosis of dyspnea - a pilot study
Popis výsledku anglicky
Background: Macrophage inhibitory cytokine-1 (MIC-1) has recently been associated with markers of heart function. Aim: This study sought to verify the relationship between markers of heart function (New York Heart Association classification (NYHA)): leftventricle ejection fraction (LVEF), N terminal prohormone of natriuretic peptide B type (NT-proBNP) and MIC-1. Furthermore, the assessment of the usefulness of these markers for differential diagnosis of the myocardial form of dyspnea was explored. Methods: 124 patients (65 women and 59 men) were examined for dyspnea without signs of acute coronary syndrome. All patients underwent echocardiography (calculation of left ventricle ejection fraction-LVEF), and serum NT-proBNP and MIC-1 were determined. 21healthy individuals were defined as the control group. Results and discussion: Patients were divided into two groups: A-individuals with non-cardiogenic form of dyspnea, n = 77 and B-individuals with cardiogenic ethiology of dyspnea, n =
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
CE - Biochemie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2009
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Clinical Biochemistry
ISSN
0009-9120
e-ISSN
—
Svazek periodika
42
Číslo periodika v rámci svazku
13-14
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
5
Strana od-do
—
Kód UT WoS článku
000272261800002
EID výsledku v databázi Scopus
—